• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prognostic value of lymphocyte count in severe COVID-19 patients with corticosteroid treatment.

作者信息

Lu Chenyang, Liu Yi, Chen Bo, Yang Hang, Hu Huifang, Liu Yi, Zhao Yi

机构信息

Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Signal Transduct Target Ther. 2021 Mar 2;6(1):106. doi: 10.1038/s41392-021-00517-3.

DOI:10.1038/s41392-021-00517-3
PMID:33654057
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7921828/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1663/7925652/eed4d92ea075/41392_2021_517_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1663/7925652/eed4d92ea075/41392_2021_517_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1663/7925652/eed4d92ea075/41392_2021_517_Fig1_HTML.jpg

相似文献

1
Prognostic value of lymphocyte count in severe COVID-19 patients with corticosteroid treatment.淋巴细胞计数在接受皮质类固醇治疗的重症COVID-19患者中的预后价值。
Signal Transduct Target Ther. 2021 Mar 2;6(1):106. doi: 10.1038/s41392-021-00517-3.
2
The role of neutrophil-lymphocyte ratio and lymphocyte-monocyte ratio in the prognosis of type 2 diabetics with COVID-19.中性粒细胞-淋巴细胞比值和淋巴细胞-单核细胞比值在 2 型糖尿病合并 COVID-19 患者预后中的作用。
Scott Med J. 2020 Nov;65(4):154-160. doi: 10.1177/0036933020953516. Epub 2020 Aug 30.
3
Lymphocyte cell population as a potential hematological index for early diagnosis of COVID-19.淋巴细胞群体作为新冠病毒病早期诊断的潜在血液学指标。
Cell Mol Biol (Noisy-le-grand). 2020 Oct 31;66(7):202-206.
4
The clinical course and its correlated immune status in COVID-19 pneumonia.新型冠状病毒肺炎的临床过程及其相关免疫状态。
J Clin Virol. 2020 Jun;127:104361. doi: 10.1016/j.jcv.2020.104361. Epub 2020 Apr 12.
5
Continuous thrombocytopenia after SARS-CoV-2 nucleic acid negative in a non-severe COVID-19 patient for several months.一名非重症 COVID-19 患者在 SARS-CoV-2 核酸阴性后连续数月出现血小板减少。
BMC Infect Dis. 2020 Oct 19;20(1):774. doi: 10.1186/s12879-020-05495-5.
6
Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.重症和危重症新型冠状病毒肺炎患者淋巴细胞亚群及相关细胞因子水平的动态变化
BMC Infect Dis. 2021 Jan 18;21(1):79. doi: 10.1186/s12879-021-05792-7.
7
Prolonged Duration of SARS-CoV-2 Viral Positivity in a Crohn's Disease Patient.一名克罗恩病患者的新冠病毒阳性持续时间延长
Inflamm Bowel Dis. 2020 Sep 18;26(10):e124. doi: 10.1093/ibd/izaa175.
8
Early predictors for mechanical ventilation in COVID-19 patients.新型冠状病毒肺炎患者机械通气的早期预测指标。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963017. doi: 10.1177/1753466620963017.
9
Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization.单核细胞绝对计数作为区分需要住院治疗的患者感染新冠病毒和甲型/乙型流感的初步工具。
Infez Med. 2020 Dec 1;28(4):534-538.
10
Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.基于细胞因子和淋巴细胞亚群组合的 SARS-CoV-2 感染预后预测模型。
J Clin Immunol. 2020 Oct;40(7):960-969. doi: 10.1007/s10875-020-00821-7. Epub 2020 Jul 13.

引用本文的文献

1
Hematologic and Immunologic Overlap Between COVID-19 and Idiopathic Pulmonary Fibrosis.新型冠状病毒肺炎与特发性肺纤维化之间的血液学和免疫学重叠
J Clin Med. 2025 Jul 24;14(15):5229. doi: 10.3390/jcm14155229.
2
Identifying Key Hematological and Biochemical Indicators of Disease Severity in COVID-19 and Non-COVID-19 Patients.识别新冠病毒感染患者和非新冠病毒感染患者疾病严重程度的关键血液学和生化指标
Diagnostics (Basel). 2025 May 29;15(11):1374. doi: 10.3390/diagnostics15111374.
3
The prognostic nutritional index is an effective prognostic and nutritional status indicator for cirrhosis.

本文引用的文献

1
Time-course analysis reveals that corticosteroids resuscitate diminished CD8+ T cells in COVID-19: a retrospective cohort study.时间进程分析显示，皮质类固醇可使 COVID-19 中减少的 CD8+T 细胞复苏：一项回顾性队列研究。
Ann Med. 2021 Dec;53(1):181-188. doi: 10.1080/07853890.2020.1851394.
2
Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome.皮质类固醇治疗急性呼吸窘迫综合征的重症 COVID-19 患者。
J Clin Invest. 2020 Dec 1;130(12):6417-6428. doi: 10.1172/JCI140617.
3
Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19.
预后营养指数是肝硬化有效的预后和营养状况指标。
BMC Gastroenterol. 2025 Feb 24;25(1):107. doi: 10.1186/s12876-025-03599-3.
4
Serum sSelectin-L is an early specific indicator of radiation injury.血清s选择素-L是辐射损伤的早期特异性指标。
Heliyon. 2024 May 8;10(10):e30527. doi: 10.1016/j.heliyon.2024.e30527. eCollection 2024 May 30.
5
A Prospective Cohort Study of COVID-19: Evaluation of the Early Role of IL-1 and IL-6 Antagonists in Improving the Outcome of the Illness and Reduction in the Risk of Death.一项关于COVID-19的前瞻性队列研究：评估白细胞介素-1和白细胞介素-6拮抗剂在改善疾病预后及降低死亡风险方面的早期作用。
Healthcare (Basel). 2023 Apr 3;11(7):1025. doi: 10.3390/healthcare11071025.
6
Development and Validation of an Acute Respiratory Distress Syndrome Prediction Model in Coronavirus Disease 2019: Updated Lung Injury Prediction Score.新型冠状病毒疾病中急性呼吸窘迫综合征预测模型的建立与验证：更新的肺损伤预测评分。
Mayo Clin Proc. 2023 May;98(5):736-747. doi: 10.1016/j.mayocp.2022.11.021. Epub 2022 Dec 30.
7
Immune-profiling of SARS-CoV-2 viremic patients reveals dysregulated innate immune responses.对 SARS-CoV-2 病毒血症患者的免疫特征分析显示，先天免疫反应失调。
Front Immunol. 2022 Nov 9;13:984553. doi: 10.3389/fimmu.2022.984553. eCollection 2022.
8
Clinical course of patients with severe SARS-CoV-2 infection co-treatment with Jin Si Herbal Tea in Eastern Taiwan: A retrospective cohort study.台湾东部严重新型冠状病毒肺炎感染患者联合饮用金丝凉茶的临床病程：一项回顾性队列研究
J Herb Med. 2022 Dec;36:100610. doi: 10.1016/j.hermed.2022.100610. Epub 2022 Oct 28.
9
pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury.pcMSC 调节 COVID-19 诱导的难治性急性肺损伤患者的免疫失调。
Front Immunol. 2022 Apr 29;13:871828. doi: 10.3389/fimmu.2022.871828. eCollection 2022.
10
A novel reliability-based regression model to analyze and forecast the severity of COVID-19 patients.一种新颖的基于可靠性的回归模型，用于分析和预测 COVID-19 患者的严重程度。
BMC Med Inform Decis Mak. 2022 May 5;22(1):123. doi: 10.1186/s12911-022-01861-2.
COVID-19 患者全身糖皮质激素治疗对死亡率或机械通气的影响。
J Hosp Med. 2020 Aug;15(8):489-493. doi: 10.12788/jhm.3497.
4
Clinical course and mortality risk of severe COVID-19.重症新型冠状病毒肺炎的临床病程及死亡风险
Lancet. 2020 Mar 28;395(10229):1014-1015. doi: 10.1016/S0140-6736(20)30633-4. Epub 2020 Mar 17.